Spire Wealth Management’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-4,300
Closed -$238K 2336
2026
Q1
$238K Buy
4,300
+400
+10% +$19K 0.01% 730
2025
Q4
$146K Buy
+3,900
New +$158K ﹤0.01% 888
2021
Q2
Sell
-12,148
Closed -$296K 2866
2021
Q1
$296K Buy
+12,148
New +$274K 0.01% 874

Other funds holding PAHC

Spire Wealth Management's PAHC Position: Q2 2026 in Review

Spire Wealth Management sold out of Phibro Animal Health (PAHC) in Q2 2026, closing a stake of 4,300 shares — an estimated $238K sold.

Spire Wealth Management first reported a position in PAHC in Q1 2021 and held it in 3 quarters. The position peaked at $296K in Q1 2021. 209 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

  • Spire Wealth Management reported no remaining Phibro Animal Health position as of Q2 2026 after selling out during the quarter.
  • Spire Wealth Management sold 4,300 Phibro Animal Health shares in Q2 2026, an estimated $238K.
  • Spire Wealth Management first reported a position in Phibro Animal Health in Q1 2021 and held it in 3 quarters.
  • Spire Wealth Management's Phibro Animal Health position peaked at $296K in Q1 2021.
  • 209 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on Spire Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.